HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maternal single injection of N-methyl-N-nitrosourea to cause microcephaly in offspring induces transient aberration of hippocampal neurogenesis in mice.

Abstract
N-Methyl-N-nitrosourea (MNU) is an alkylating agent having antiproliferative cytotoxity targeting the neural stem/progenitor cells to cause microcephaly by maternal exposure. This study investigated the effect of transient exposure to MNU on the process of hippocampal neurogenesis in later life using mice. Pregnant mice received a single injection of MNU at 0, 5 and 10 mg/kg body weight, intraperitoneally on gestational day 14, and their offspring were examined on postnatal day (PND) 21 and PND 77. On PND 21, offspring displayed microcephaly and hippocampal formation hypoplasia at 10 mg/kg, decrease of doublecortin (Dcx)(+) cells in the dentate subgranular zone from 5mg/kg, and decrease of TUNEL(+) apoptotic cells and increase of transcript expression of anti-apoptotic Bcl-2 at 10 mg/kg in the dentate gyrus. In the dentate hilus, numbers of reelin(+) or parvalbumin (Pvalb)(+) interneurons or neuron-specific nuclear protein(+) neurons increased at 10 mg/kg. Microcephaly and hippocampal formation hypoplasia continued through PND 77 at 10 mg/kg. Thus, apart from the massive cell killing at the migratory stream causing microcephaly, MNU may decrease Dcx(+) cells reflecting disruption of the differentiation process of late-stage neuronal progenitors and immature granule cells through defective molecular functions by gene mutations. Increase of reelin(+) and Pvalb(+) cells may reflect the disruption of neurogenesis and following neuronal migration. All of the granule cell lineage and interneuron changes disappeared at the adult stage on PND 77 suggesting that MNU mainly targets transient populations of highly proliferative progenitor cells but hardly affects their stem cells having self-renewal ability.
AuthorsNorifumi Takimoto, Liyun Wang, Megu Itahashi, Takashi Ogawa, Risa Segawa, Shintaro Hara, Tomoaki Murakami, Kazuhiko Suzuki, Makoto Shibutani
JournalToxicology letters (Toxicol Lett) Vol. 226 Issue 1 Pg. 20-7 (Apr 07 2014) ISSN: 1879-3169 [Electronic] Netherlands
PMID24463056 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Alkylating Agents
  • Cell Adhesion Molecules, Neuronal
  • Dcx protein, mouse
  • Doublecortin Domain Proteins
  • Doublecortin Protein
  • Extracellular Matrix Proteins
  • Microtubule-Associated Proteins
  • Nerve Tissue Proteins
  • Neuropeptides
  • Parvalbumins
  • Proto-Oncogene Proteins c-bcl-2
  • Reelin Protein
  • Methylnitrosourea
  • Reln protein, mouse
  • Serine Endopeptidases
Topics
  • Alkylating Agents (toxicity)
  • Animals
  • Apoptosis (drug effects)
  • Cell Adhesion Molecules, Neuronal (genetics, metabolism)
  • Cell Lineage
  • Cell Proliferation (drug effects)
  • Doublecortin Domain Proteins
  • Doublecortin Protein
  • Extracellular Matrix Proteins (genetics, metabolism)
  • Female
  • Gestational Age
  • Hippocampus (drug effects, metabolism, pathology, physiopathology)
  • Injections, Intraperitoneal
  • Interneurons (drug effects, metabolism, pathology)
  • Male
  • Maternal Exposure
  • Methylnitrosourea (toxicity)
  • Mice
  • Mice, Inbred ICR
  • Microcephaly (chemically induced, genetics, metabolism, pathology, physiopathology)
  • Microtubule-Associated Proteins (metabolism)
  • Nerve Tissue Proteins (genetics, metabolism)
  • Neural Stem Cells (drug effects, metabolism, pathology)
  • Neurogenesis (drug effects)
  • Neuropeptides (metabolism)
  • Parvalbumins (genetics, metabolism)
  • Pregnancy
  • Prenatal Exposure Delayed Effects
  • Proto-Oncogene Proteins c-bcl-2 (genetics, metabolism)
  • Reelin Protein
  • Serine Endopeptidases (genetics, metabolism)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: